MYNZ Stock Discussion

Mainz Biomed B.V. Description

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Cancer Clinical Medicine Medical Genetics Medical Test Pancreatic Cancer Colorectal Cancer Molecular Diagnostics Diagnostic Tests Cancer Screening Innogenetics